Clinical Trials in San Francisco

Showing 8401-8420 of 12,991 trials

Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

NCT01463046

The purpose of this study is to see if Panobinostat is safe to give to patients and to determine the best dose to give in combination with standard cytarabine and daunorubicin chemotherapy.

Acute Myeloid LeukemiaAdvanced Myelodysplastic Syndrome

University of California, San Francisco29 participantsStarted Jan 2012

San Francisco, California, United States

COMPLETEDPhase 1< 1 mile

CTT1057, a Small Molecular Inhibitor of PSMA, as a Novel Imaging Agent of Neovascularization in Renal Cell Carcinoma

NCT03427476

The purpose of this study is to test a novel diagnostic PET imaging agent for safety and biodistribution. The agent binds PSMA and is designed to detect Prostate Specific Membrane Antigen expressing tumors, such as has been described for some renal cell carcinoma tumors.

Renal Cell Carcinoma

Cancer Targeted Technology4 participantsStarted Jan 2018

San Francisco, California, United States

Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

CTT1057, a Small Molecular Inhibitor of PSMA, as a Novel Imaging Agent of Neovascularization in Renal Cell Carcinoma

Find Trials by Condition in San Francisco

Broad-spectrum Cognitive Remediation: Effects of a Brain Plasticity-based Program in Mild Traumatic Brain Injury

WALK Study: Women's Active Living for Koreans Study

Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus

Retinol on Human Skin Aging in East Asian Descent

Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes

Evaluation of Technology-Based Stress Reduction Techniques Prior to Vascular Access

A Comprehensive Study to Isolate Tumor-initiating Cells From Human Epithelial Malignancies

Prospective Evaluation of Winged Biliary Stent Patency in Patients With Benign Biliary Obstruction

Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke

Pilot Study of alpha1-antitrypsin to Treat Neuromyelitis Optica Relapses

Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease

Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy

A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy

Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations

Dissonance Eating Disorder Prevention: Clinician Led, Peer Led vs Web Delivered

Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions

24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis